DevCo has completed a strategic capital raise for its long-term investment in Medix Biochemica
September 16, 2024
September 16, 2024
September 6, 2024
August 1, 2024
July 10, 2024
July 8, 2024
July 2, 2024
May 22, 2024
May 14, 2024
May 6, 2024
September 16, 2024
Following the capital raise, DevCo’s single-asset investment vehicle for Medix Biochemica has total long term commitments of 616 MEUR The capital rais...
September 11, 2024
Advancing structural biology research with the GenNext AutoFox® Protein Footprinting System and Agilent 6560 Ion Mobility Quadrupole Time-of-Flight (I...
September 6, 2024
The Diagnostics & Research Institute for Pathology at the Medical University of Graz, a leader in personalized patient care and one of the largest...
Life Science Newswire is a division of BioStrata.
BioStrata Ltd., Endurance House, Vision Park, Histon, Cambridge, CB249ZR,
Company registration: 8233225